| 抗病毒颗粒的临床研究现状 |
| |
| 引用本文： | 张凡,李东,尚强.抗病毒颗粒的临床研究现状[J].中国临床药理学杂志,2021(1). |
| |
| 作者姓名： | 张凡 李东 尚强 |
| |
| 作者单位： | 北京大学临床药理研究所;国家中药现代化工程技术研究中心 |
| |
| 摘 要： | 抗病毒颗粒是根据经典名方研制而成的,用于治疗上呼吸道感染及流行性感冒的独家中药复方制剂。本文综述了抗病毒颗粒在新发传染性疾病和新型冠状病毒肺炎(COVID-19)等疾病领域的临床应用潜在价值。
|
| 关 键 词： | 抗病毒颗粒 新发传染性疾病 新型冠状病毒肺炎 临床应用 |
Current situation of clinical trial of Kangbingdu Keli |
| |
| ZHANG Fan,LI Dong,SHANG Qiang.Current situation of clinical trial of Kangbingdu Keli[J].The Chinese Journal of Clinical Pharmacology,2021(1). |
| |
| Authors: | ZHANG Fan LI Dong SHANG Qiang |
| |
| Institution: | (Institute of Clinical Pharmacology,Peking University,Beijing 100034,China;National Engineering Research Center for Modernazation of Traditional Chinese Medicine,Zhuhai 519085,Guangdong Province,China) |
| |
| Abstract: | Kangbingdu Keli was an exclusive compound preparation of traditional Chinese medicine for the treatment of upper respiratory tract infection and influenza.This paper reviewed the potential clinical value of antiviral particles in the field of emerging infectious diseases and corona virus disease 2019(COVID-19). |
| |
| Keywords: | Kangbingdu Keli emerging infectious diseases corona virus disease 2019 clinical application |
| 本文献已被 维普 等数据库收录！ |
